צמיחת הכנסות משנה לשנה ב-12 החודשים האחרונים: Amphastar Pharmaceuticals (AMPH)

Amphastar Pharmaceuticals (AMPH) maintains a grip on nearly all US hospital networks due to a shortage of complex injectable drugs. The current TTM sales growth trend captures this success. Proprietary manufacturing plants in Europe, China, and America guarantee production stability. High margins are achieved through capital-intensive sterile fill-finish lines. The 3.20 indicator expresses the metric's value today.
פילוחי נתונים אנליטיים מרוכזים עבור Amphastar Pharmaceuticals Inc (AMPH)

This indicator measures the annual revenue growth rate over a rolling 12-month period, neutralizing quarterly volatility and revealing the true resilience of the business to market shocks. An analysis of the TTM revenue YoY dynamics confirms the effectiveness of the vertical integration of Amphastar Pharmaceuticals (AMPH), demonstrating the stability of demand for its critical injectable drugs amid stringent hospital demand.